UCLA Cardiovascular Research

The UCLA Lipshutz Hepatic Regenerative Medicine Lab focuses on developing gene and cell-based therapies aimed at treating metabolic liver diseases that can lead to intellectual disabilities in children. Their research encompasses various directions, including gene therapy for nitrogen metabolism restoration and exploring neurobiology related to specific enzyme deficiencies. Recent achievements from the lab include notable publications on innovative therapies for conditions like carbamoyl phosphate synthetase 1 deficiency and arginase deficiency. The lab is dedicated to advancing understanding and treatment options for these complex metabolic disorders through cutting-edge research and collaboration. Generated from the website

Visit the UCLA Health website for coronavirus updates.